Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wednesday, April 18, 2012 - 12:11pm
tags:
BB1608, Boston Biomedical, Dainippon Sumitomo, cabozantinib, Exelixis, ONYX Pharmaceuticals, Carfilzomib, Medivation, Astellas, Enzalutamide, Ariad Pharmaceuticals, Ponatinib, Bayer, regorafenib, Oncovex, Amgen, Roche, Genentech, T-DM1, Immunogen, Aveo, tivozanib, Zaltrap, Sanofi, Regeneron
Is Pfizer Dropping Out of the Baby Business?
Wall St. Cheat Sheet
Wednesday, April 18, 2012 - 12:03pm
tags:
Pfizer, infant nutrition, Mead Johnson, Danone SA, Abbott Laboratories
Arena Pharma's Own Data Point to Weight-Loss Drug Rejection
TheStreet.com
Wednesday, April 18, 2012 - 11:43am
tags:
obesity, Arena, lorcaserin
Eli Lilly Will Sink If Solanezumab Fails
Seeking Alpha
Wednesday, April 18, 2012 - 11:42am
tags:
solanezumab, Eli Lilly, GSK, JNJ, Pfizer, Sanofi, Alzheimer's disease
A Reasoned Case For Avanafil Approval
Seeking Alpha
Wednesday, April 18, 2012 - 11:40am
tags:
Avanafil, Vivus, Pfizer, Sanofi, erectile dysfunction
Endocyte Gets Big Deal But More Validation Needed
Seeking Alpha
Wednesday, April 18, 2012 - 11:39am
tags:
Merck, Endocyte, EC145, ovarian cancer
Abbott beats Street, lifts 2012 forecast
Reuters
Wednesday, April 18, 2012 - 11:38am
tags:
Abbott Laboratories, earnings
MAP Pharmaceutical: Timeline Of The NDA Resubmission
Seeking Alpha
Wednesday, April 18, 2012 - 10:13am
tags:
MAP Pharmaceuticals, Levadex, FDA
Roche not to extend tender offer for Illumina
Markewatch
Wednesday, April 18, 2012 - 10:02am
tags:
Roche, M&A, Illumina
Medivir Announces TMC435 in an Expanded Clinical Collaboration
Yahoo
Wednesday, April 18, 2012 - 9:14am
tags:
Medivir, TMC435, Janssen, Bristol-Myers Squibb, daclatasvir, hepatitis C
Popular J.&J. Drugs May Not Return Until 2013
NY Times, NY
Wednesday, April 18, 2012 - 9:13am
tags:
JNJ
Pfizer Nears Sale of Infant Nutrition Unit to Nestle
Yahoo/NY Times
Wednesday, April 18, 2012 - 9:12am
tags:
infant nutrition, Nestle, Pfizer, M&A
New J&J CEO's ties to fraud case show J&J sees no need for a cure
Forbes
Tuesday, April 17, 2012 - 10:59am
tags:
JNJ, fraud, Alex Gorsky
Sales Reps, Overtime & The Labor Dept
Pharmalot
Tuesday, April 17, 2012 - 10:45am
tags:
overtime lawsuits, Department of Labor, drug reps
Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth
Seeking Alpha
Tuesday, April 17, 2012 - 10:42am
tags:
Fusilev, physicians, Spectrum Pharmaceuticals, Allos, Teva Pharmaceuticals
NeurogesX seeks partners for pain drugs
Reuters
Tuesday, April 17, 2012 - 10:40am
tags:
NeurogesX, Qutenza, neuropathic pain
Forest Laboratories Inc. Earnings: Four Quarters in a Row of Falling Profit
Wall St. Cheat Sheet
Tuesday, April 17, 2012 - 10:39am
tags:
Forest Labs, earnings
Illumina Win in Board Contest May Signal Long Roche Fight
Bloomberg
Tuesday, April 17, 2012 - 10:29am
tags:
Roche, M&A, Illumina
Sequenom rises on new Down Syndrome test forecast
Yahoo/AP
Tuesday, April 17, 2012 - 10:26am
tags:
Downs Syndrome, Sequenom, MaterniT21
Pharmacy benefits manager Express Scripts sees slower growth in prescription drug spending
Yahoo/AP
Tuesday, April 17, 2012 - 10:22am
tags:
drug sales, Express Scripts

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.